SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-097373
Filing Date
2023-08-31
Accepted
2023-08-31 20:10:32
Documents
1
Period of Report
2023-08-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2325325-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2325325-2_3seq1.xml 3 1517
  Complete submission text file 0001104659-23-097373.txt   3115
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 BOSTON MA 02210
Business Address
Basso Stephen (Reporting) CIK: 0001815707 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 231230404